[Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma].

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archivos de Bronconeumologia

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.arbres.2011.04.010PMID 21696876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of p 53 and epidermal growth factor receptor expression in resected surgical-pathologic t 1 non-small cell lung cancer : analysis in combination with histopathological factors

  2007cited by this paper
• Immunohistochemical Analysis of Non-Small Cell Lung Cancer: Correlation with Clinical Parameters and Prognosis

  2007cited by this paper
• Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

  2007cited by this paper
• Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer.

  2005cited by this paper
• Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer

  2005cited by this paper
• Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer.

  2004cited by this paper
• Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma

  2004cited by this paper
• Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer

  2004cited by this paper
• The Biology of Epidermal Growth Factor Receptor in Lung Cancer

  2004cited by this paper
• Prognostic Factors in Resected Pathologic (p-) Stage IIIA-N2, Non-Small-Cell Lung Cancer

  2004cited by this paper
• Pathology & Genetics Tumours of the lung, Pleura, Thymus and Heart

  2004cited by this paper
• Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

  2003cited by this paper
• P-484 Synchronous overexpression of epidermal growth factor receptor and HER2-NEU is a predictor of poor outcome in patients with stage I non-small cell lung cancer

  2003cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Diagnostic value of plasma vascular endothelial growth factor as a tumor marker in patients with non-small cell lung cancer.

  2002cited by this paper
• High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

  2002cited by this paper
• Serum endostatin correlates with progression and prognosis of non-small cell lung cancer.

  2002cited by this paper
• Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer.

  2001cited by this paper
• General thoracic surgery, 5th ed

  2000cited by this paper
• Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance

  2000cited by this paper
• Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.

  2000cited by this paper
• Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

  2000cited by this paper
• Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas.

  1999cited by this paper
• A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

  1999cited by this paper
• The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.

  1998cited by this paper
• Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.

  1998cited by this paper
• Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer.

  1998cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

  1997cited by this paper
• Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.

  1996cited by this paper
• Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.

  1992cited by this paper
• [Clinical evaluation of serum NSE and CEA in primary lung cancer patients].

  1986cited by this paper
• General Thoracic Surgery

  1972cited by this paper
• Overexpression of the Epidermal Growth Factor Receptor and Its Ligand Transforming Growth Factor a Is Frequent in Resectable Non-small Cell Lung Cancer but Does Not Predict Tumor Progression' Egfr and Tgf-a Overexpression Was Observed in All Tumor

  year unknowncited by this paper

• Oncologic Outcomes of Surgery Versus SBRT for Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis.

  2020cites this paper
• p120‐catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C‐γ1 signaling

  2020cites this paper
• Epidermal growth factor receptor protein expression in lung cancer and survival analysis

  2018cites this paper
• Studies on the pathophysiology of bile acid-induced inflammatory airways disease

  2017cites this paper
• Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.

  2015cites this paper
• Reduced E-Cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjects.

  2014cites this paper
• Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis

  2014influential citation
• Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up

  2014cites this paper
• Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.

  2014cites this paper
• [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].

  2014cites this paper
• The effect of TTF-1 expression on ipsilateral mediastinal nodal (N2) metastases in primary adenocarcinoma of the lung

  2013cites this paper
• Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.

  2013cites this paper
• Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD.

  2013influential citation
• Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β‐catenin, in primary lung adenocarcinoma—their prognostic significance

  2012cites this paper
• FH535 Potentiation of Cigarette Smoke Condensate Cytotoxicity is Associated With Changes in β-Catenin and EGR-1 Signaling

  2012cites this paper
• The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis

  2012cites this paper
• Alteration in Metastasis Potential and Gene Expression in Human Lung Cancer Cell Lines by ITGB8 Silencing

  2012cites this paper
• Overexpression of FOXM 1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer

  year unknowncites this paper